M&A Deal Summary |
|
|---|---|
| Date | 2023-05-03 |
| Target | Invitros |
| Sector | Medical Products |
| Buyer(s) | Glenwood Private Equity |
| Sellers(s) | LG Chem |
| Deal Type | Divestiture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Glenwood Private Equity is a private equity firm specializing in buyouts and corporate carve-outs across South Korea. Prospective transactions include leveraged buyouts, mezzanine and subordinated debt investments, and structured credit strategies that address both equity and financing needs. The Firm's sector expertise spans manufacturing, healthcare, and industrial services. Glenwood Private Equity was founded in 2014 and is headquartered in Seoul.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: South Korea M&A | 3 of 3 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-23 |
Olive Young
Seoul, South Korea Olive Young is the first Korean health and beauty retailer with 1,200+ offline stores as well as a fast-growing online platform serving both domestic and global markets. Olive Young was founded in 1999 and is based in Seoul, South Korea. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-12-01 |
PI Advanced Materials
Seoul, South Korea PI Advanced Materials (PIAM) is a producer of polyimide film for advanced industries such as display, semiconductors, and electric vehicles. PI Advanced Materials is based in Seoul, South Korea. |
Sell | - |
LG Chem engaged in manufacture of petrochemicals like polyvinyl chloride (PVC) resins, low-density polyethylene (LDPE), poly styrene (PS), acrylonitrile butadiene styrene (ABS), bisphenol. LG Chem was founded in 1947 and is based in Seoul, South Korea.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 3 of 3 |
| Country: South Korea M&A | 2 of 2 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-19 |
Aveo Oncology
Boston, Massachusetts, United States Aveo Oncology is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. Aveo Oncology's product candidates are targeted against important mechanisms known or believed to be involved in cancer. Aveo Oncology was founded in 2001 and is based in Boston, Massachusetts. |
Buy | $571M |
